Literature DB >> 29594739

The IBD and PSC Phenotypes of PSC-IBD.

Amanda Ricciuto1, Binita M Kamath2, Anne M Griffiths2.   

Abstract

PURPOSE OF REVIEW: To review the characteristics of IBD and PSC that occur in association, as well as their reciprocal influences on disease evolution, in adult and pediatric populations. RECENT
FINDINGS: IBD co-existing with PSC is genetically and clinically distinct from IBD alone. It is frequently characterized by pancolitis, rectal sparing, and possibly backwash ileitis, as well as a threefold increased risk of colorectal dysplasia. Adults and children with colitis and PSC appear to be at increased risk of active endoscopic and histologic disease in the absence of symptoms compared to individuals without PSC. PSC occurring with Crohn's disease has been observed to be less severe than PSC co-existing with ulcerative colitis, independent of its association with small duct disease. Recent studies suggest that colectomy is associated with a decreased risk of recurrent PSC after liver transplantation, challenging the traditional teaching that PSC and IBD evolve independently. While much about the gut-liver axis in PSC-IBD remains poorly understood, the IBD associated with PSC has a unique phenotype, of which subclinical inflammation is an important component. Additional research is needed to characterize further the potentially protective role of colectomy against recurrent PSC post-liver transplantation and to investigate the influence of IBD control and/or colectomy on PSC progression.

Entities:  

Keywords:  Colectomy; Inflammatory bowel disease (IBD); Liver transplantation; PSC-IBD; Phenotype; Primary sclerosing cholangitis (PSC)

Mesh:

Year:  2018        PMID: 29594739     DOI: 10.1007/s11894-018-0620-2

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  98 in total

1.  Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis.

Authors:  Hitoshi Sano; Takahiro Nakazawa; Tomoaki Ando; Kazuki Hayashi; Itaru Naitoh; Fumihiro Okumura; Katsuyuki Miyabe; Michihiro Yoshida; Satoru Takahashi; Hirotaka Ohara; Takashi Joh
Journal:  J Hepatobiliary Pancreat Sci       Date:  2011-03       Impact factor: 7.027

Review 2.  Immunosuppressive Agents for the Treatment of Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis.

Authors:  Xia Peng; Xin Luo; Jing-Ying Hou; Shu-Yun Wu; Liang-Zong Li; Ming-Hua Zheng; Ling-Yun Wang
Journal:  Dig Dis       Date:  2017-05-06       Impact factor: 2.404

3.  Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

Authors:  K M Boberg; A Bergquist; S Mitchell; A Pares; F Rosina; U Broomé; R Chapman; O Fausa; T Egeland; G Rocca; E Schrumpf
Journal:  Scand J Gastroenterol       Date:  2002-10       Impact factor: 2.423

4.  Pediatric ulcerative colitis associated with autoimmune diseases: a distinct form of inflammatory bowel disease?

Authors:  Felipe Ordonez; Florence Lacaille; Danielle Canioni; Cecile Talbotec; Jean-Christophe Fournet; Nadine Cerf-Bensussan; Olivier Goulet; Jacques Schmitz; Frank M Ruemmele
Journal:  Inflamm Bowel Dis       Date:  2012-01-11       Impact factor: 5.325

5.  The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.

Authors:  Mark R Deneau; Wael El-Matary; Pamela L Valentino; Reham Abdou; Khaled Alqoaer; Mansi Amin; Achiya Z Amir; Marcus Auth; Fateh Bazerbachi; Annemarie Broderick; Albert Chan; Jillian Cotter; Sylvia Doan; Mounif El-Youssef; Federica Ferrari; Katryn N Furuya; Madeleine Gottrand; Frederic Gottrand; Nitika Gupta; Matjaz Homan; Binita M Kamath; Kyung Mo Kim; Kaija-Leena Kolho; Anastasia Konidari; Bart Koot; Raffaele Iorio; Oren Ledder; Cara Mack; Mercedes Martinez; Tamir Miloh; Parvathi Mohan; Niamh O'Cathain; Alexandra Papadopoulou; Amanda Ricciuto; Lawrence Saubermann; Pushpa Sathya; Eyal Shteyer; Vratislav Smolka; Atushi Tanaka; Raghu Varier; Veena Venkat; Bernadette Vitola; Miriam B Vos; Marek Woynarowski; Jason Yap; M Kyle Jensen
Journal:  Hepatology       Date:  2017-06-26       Impact factor: 17.425

6.  Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history.

Authors:  Mark Deneau; M Kyle Jensen; John Holmen; Marc S Williams; Linda S Book; Stephen L Guthery
Journal:  Hepatology       Date:  2013-08-13       Impact factor: 17.425

7.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

Authors:  Matthew Rutter; Brian Saunders; Kay Wilkinson; Steve Rumbles; Gillian Schofield; Michael Kamm; Christopher Williams; Ashley Price; Ian Talbot; Alastair Forbes
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

8.  Inflammatory bowel disease in primary sclerosing cholangitis: a robust yet changing relationship.

Authors:  Emmanouil Sinakos; Sunil Samuel; Felicity Enders; Edward V Loftus; William J Sandborn; Keith D Lindor
Journal:  Inflamm Bowel Dis       Date:  2013-04       Impact factor: 5.325

9.  The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.

Authors:  Martin Kummen; Kristian Holm; Jarl Andreas Anmarkrud; Ståle Nygård; Mette Vesterhus; Marte L Høivik; Marius Trøseid; Hanns-Ulrich Marschall; Erik Schrumpf; Bjørn Moum; Helge Røsjø; Pål Aukrust; Tom H Karlsen; Johannes R Hov
Journal:  Gut       Date:  2016-02-17       Impact factor: 23.059

10.  A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.

Authors:  Edward Alabraba; Peter Nightingale; Bridget Gunson; Stefan Hubscher; Simon Olliff; Darius Mirza; James Neuberger
Journal:  Liver Transpl       Date:  2009-03       Impact factor: 5.799

View more
  11 in total

Review 1.  Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases.

Authors:  Shintaro Akiyama; Soma Fukuda; Joshua M Steinberg; Hideo Suzuki; Kiichiro Tsuchiya
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

2.  Is primary sclerosing cholangitis with inflammatory bowel disease different between patients in the East and West?

Authors:  Yong Eun Park
Journal:  Intest Res       Date:  2022-04-29

Review 3.  Gut microbiome in primary sclerosing cholangitis: A review.

Authors:  Rebecca Little; Eytan Wine; Binita M Kamath; Anne M Griffiths; Amanda Ricciuto
Journal:  World J Gastroenterol       Date:  2020-06-07       Impact factor: 5.742

4.  Antineutrophil cytoplasmic antibody profiles differ according to type of primary sclerosing cholangitis and autoimmune hepatitis.

Authors:  Juliana Goldbaum Crescente; Alessandra Dellavance; Marcio Augusto Diniz; Flair Jose Carrilho; Luis Eduardo Coelho de Andrade; Eduardo Luiz Rachid Cançado
Journal:  Clinics (Sao Paulo)       Date:  2021-02-05       Impact factor: 2.365

5.  The impact of primary sclerosing cholangitis or inflammatory bowel disease on cholangiocarcinoma phenotype, therapy, and survival.

Authors:  Daljeet Chahal; Chris Shamatutu; Bill Salh; Janine Davies
Journal:  JGH Open       Date:  2020-08-11

6.  Causal Linkage Between Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Two-Sample Mendelian Randomization Analysis.

Authors:  Ying Xie; Xuejie Chen; Minzi Deng; Yuhao Sun; Xiaoyan Wang; Jie Chen; Changzheng Yuan; Therese Hesketh
Journal:  Front Genet       Date:  2021-03-18       Impact factor: 4.599

Review 7.  Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.

Authors:  Fotios S Fousekis; Vasileios I Theopistos; Ioannis V Mitselos; Alexandros Skamnelos; Athanasios Kavvadias; Konstantinos H Katsanos; Dimitrios K Christodoulou
Journal:  J Clin Med Res       Date:  2019-01-05

Review 8.  Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders.

Authors:  Stefano Mazza; Sara Soro; Maria Chiara Verga; Biagio Elvo; Francesca Ferretti; Fabrizio Cereatti; Andrea Drago; Roberto Grassia
Journal:  World J Hepatol       Date:  2021-12-27

Review 9.  Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives.

Authors:  Snehali Majumder; Uday Nagesh Shivaji; Rangarajan Kasturi; Alben Sigamani; Subrata Ghosh; Marietta Iacucci
Journal:  World J Gastrointest Oncol       Date:  2022-03-15

10.  Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.

Authors:  Jingru Yu; Erle Refsum; Lise M Helsingen; Trine Folseraas; Alexander Ploner; Paulina Wieszczy; Ishita Barua; Henriette C Jodal; Espen Melum; Magnus Løberg; Johannes Blom; Michael Bretthauer; Hans-Olov Adami; Mette Kalager; Weimin Ye
Journal:  United European Gastroenterol J       Date:  2022-02-02       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.